KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Receivables (2016 - 2025)

Medpace Holdings' Receivables history spans 11 years, with the latest figure at $427.4 million for Q4 2025.

  • For Q4 2025, Receivables rose 41.63% year-over-year to $427.4 million; the TTM value through Dec 2025 reached $427.4 million, up 41.63%, while the annual FY2025 figure was $427.4 million, 41.63% up from the prior year.
  • Receivables reached $427.4 million in Q4 2025 per MEDP's latest filing, up from $383.8 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $427.4 million in Q4 2025 to a low of $160.3 million in Q1 2021.
  • Average Receivables over 5 years is $292.9 million, with a median of $300.7 million recorded in 2023.
  • Peak YoY movement for Receivables: dropped 5.95% in 2024, then surged 41.63% in 2025.
  • A 5-year view of Receivables shows it stood at $222.5 million in 2021, then soared by 32.03% to $293.8 million in 2022, then grew by 9.21% to $320.9 million in 2023, then fell by 5.95% to $301.8 million in 2024, then surged by 41.63% to $427.4 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Receivables are $427.4 million (Q4 2025), $383.8 million (Q3 2025), and $383.9 million (Q2 2025).